KL-6 producing invasive thymoma

Internal Medicine

Volumn 41, Issue 11, 2002, Pages 979-982

  Kawata, Tadayoshi ^a   Tsukagoshi, Hideo ^a   Mashimo, Toshiyuki ^a   Karizaki, Satoru ^a   Kasahara, Takayuki ^a   Iwasaki, Junko ^a   Shimizu, Yuji ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Interstitial pneumonia; Liver metastasis; MUC1; Mucin like high molecular weight glycoprotein; Tumor marker

Indexed keywords

CONTRAST MEDIUM; GLUCOCORTICOID; GLYCOPROTEIN; MUCIN;

ADULT; ARTICLE; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSPNEA; FATIGUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL PNEUMONIA; LIVER METASTASIS; LIVER TUMOR; MALE; MEDIASTINUM TUMOR; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; THYMOMA; TUMOR CELL; MIDDLE AGED; PATHOLOGY; SECRETION;

HUMANS; MALE; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; THYMOMA; THYMUS NEOPLASMS;

EID: 0036857553     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.979     Document Type: Article

References (14)

1. Strollo DC, Rosado-de-Christenson ML. Tumors of the thymus. J Thorac Imaging 14: 152-171, 1999.
2. Graeber GM, Tamim W. Current status of the diagnosis and treatment of thymoma. Semin Thorac Cardiovasc Surg 12: 268-277, 2000.
3. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96: 68-73, 1989.
4. Hiraga Y, Tanaka S, Haruma K, et al. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 55: 307-319, 1998.
5. Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 40: 92-100, 2002.
6. Kraus S, Abel PD, Nachtmann C, et al. MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis. Hum Pathol 33: 60-67, 2002.
7. Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 26: 466-471, 2002.
8. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94: 624-632, 2002.
9. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492, 1981.
10. Stahel RA, Gilks WR, Lehmann HP, Schenker T. Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis. Int J Cancer (Suppl) 8: 6-26, 1994.
11. von Mensdorff-Pouilly S, Snijdewint FGM, Verstraeten AA, Verheijen RHM, Kenemans P. Human MUC1 mucin: a multifaceted glycoprotein Int J Biol Markers 15: 343-356, 2000.
12. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129: 255-265, 1995.
13. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7: 565-577, 1996.
14. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18: 203-216, 1988.